Republican lawmakers have proposed a raft of cost-cutting measures that could limit access to Medicaid and Medicare. Why It Matters Funding cuts and regulatory changes could radically reduce Medicaid,

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by introducing floors.

For retirees, there are generally two big surprises when it comes to Medicare. The first is that Medicare is not actually free. The retirement program is America's closest thing to universal health insurance,

The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.

Seniors pay about the same or slightly less out-of-pocket for services under Medicare Advantage compared to traditional Medicare, researchers found. For example, Medicare Advantage beneficiaries paid nearly $206 for eyeglasses, about 9% less than the $226 paid under traditional Medicare.

Original Medicare's cost and coverage change annually. This affects how much you pay and the type of supplementary insurance you may want.

There are some drawbacks to Medicare Advantage plans though. Restricted provider networks can be a hurdle for people who travel a lot or are snowbirds. And those who have been on a traditional Medicare plan may find themselves suddenly having to deal with prior authorizations.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.

California has various Medicare options, including Original Medicare, Medicare Advantage, and Medigap. Learn more here.

The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the study found.